Rene Bernards - Oct 2, 2023 Form 4/A - Amendment Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director
Signature
/s/ Rene Bernards
Stock symbol
LIXT
Transactions as of
Oct 2, 2023
Transactions value $
$24,116
Form type
4/A - Amendment
Date filed
10/5/2023, 08:39 PM
Date Of Original Report
Oct 4, 2023
Previous filing
Dec 16, 2022
Next filing
Jul 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIXT Common Stock Purchase $10.2K +4.47K +29.82% $2.29 19.5K Oct 2, 2023 Direct F1
transaction LIXT Common Stock Purchase $13.9K +5.53K +28.38% $2.51 25K Oct 3, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired an aggregate of 4,473 shares in numerous trades at prices ranging from $2.29-$2.40
F2 The Reporting Person acquired an aggregate of 5,527 shares in numerous trades ranging from $2.51-$2.58

Remarks:

This amended Form 4 corrects the amount of shares beneficially owned